The purpose of the experimental study was to design a sustained release film formulation of metformin hydrochloride. In this study a transdermal film has been prepared by incorporating hydrophilic polymers like HPMC and PVA in combination of different ratios. The prepared film were subjected for different evaluation parameters like swelling index study, surface pH, drug content analysis, thickness of film, folding endurance study, drug release study. Results of evaluation of all the film was found satisfactory. Again further study needs to be conducted to stabilize the formulation
Copyright © 2012 Amitava Roy et al. This is an open access article distributed under the Creative Co...
In this research study an attempt was made to formulate sustained release matrix tablets of Metformi...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...
The purpose of the experimental study was to design a sustained release film formulation of metformi...
ABSTRACT The present study was investigated to transdermal patch formulation of Metformin hydrochlo...
Objective: Present study was carried to formulate and evaluate the transdermal ointment containing t...
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the manageme...
The objective of the present study was to study the effect of hydrophilic polymers on sustained rele...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
This present study was to develop a suitable matrix-type transdermal drug delivery system (TDDS) of ...
 Objective: The aim of this investigation was to develop and optimize metformin hydrochloride matri...
The low bioavailability and short half-life of Metformin hydrochloride (MH) make the development of ...
To develop an oral sustained release Metformin HCl tablet by wet granulation technique, using differ...
Metformin is widely used for the treatment of diabetes; the intention of the present study was to fo...
Copyright © 2012 Amitava Roy et al. This is an open access article distributed under the Creative Co...
In this research study an attempt was made to formulate sustained release matrix tablets of Metformi...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...
The purpose of the experimental study was to design a sustained release film formulation of metformi...
ABSTRACT The present study was investigated to transdermal patch formulation of Metformin hydrochlo...
Objective: Present study was carried to formulate and evaluate the transdermal ointment containing t...
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the manageme...
The objective of the present study was to study the effect of hydrophilic polymers on sustained rele...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
This present study was to develop a suitable matrix-type transdermal drug delivery system (TDDS) of ...
 Objective: The aim of this investigation was to develop and optimize metformin hydrochloride matri...
The low bioavailability and short half-life of Metformin hydrochloride (MH) make the development of ...
To develop an oral sustained release Metformin HCl tablet by wet granulation technique, using differ...
Metformin is widely used for the treatment of diabetes; the intention of the present study was to fo...
Copyright © 2012 Amitava Roy et al. This is an open access article distributed under the Creative Co...
In this research study an attempt was made to formulate sustained release matrix tablets of Metformi...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...